Delaware Intellectual Property Cases
Cases 1 - 10 of 1,264
Novartis Pharmaceuticals Corporation et al v. Lupin Limited et al
as 1:2025cv00578
Plaintiff:
Novartis Pharmaceuticals Corporation and Novartis AG
Defendant:
Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AVEO Pharmaceuticals, Inc. v. Somerset Therapeutics, LLC et al
as 1:2025cv00560
Defendant:
Somerset Therapeutics Private Limited, Somerset Therapeutics, LLC, Somerset Pharma, LLC and others
Plaintiff:
AVEO Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
as 1:2025cv00563
Plaintiff:
Azurity Pharmaceuticals, Inc.
Defendant:
Alkem Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Pfizer Inc. et al v. Alkem Laboratories Limited
as 1:2025cv00565
Plaintiff:
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V. and others
Defendant:
Alkem Laboratories Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vifor (International) AG et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.
as 1:2025cv00540
Plaintiff:
Vifor (International) AG and American Regent, Inc.
Defendant:
Orbicular Pharmaceutical Technologies Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Aurinia Pharmaceuticals Inc. v. DifGen Pharmaceuticals LLC
as 1:2025cv00530
Plaintiff:
Aurinia Pharmaceuticals Inc.
Defendant:
DifGen Pharmaceuticals LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Biocon Limited et al
as 1:2025cv00523
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG
Defendant:
Biocon Limited, Biocon Pharma Limited and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Neurocrine Biosciences, Inc. v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2025cv00509
Plaintiff:
Neurocrine Biosciences, Inc.
Defendant:
Zydus Pharmaceuticals (USA) Inc., Zydus Lifesciences Global FZE, Zydus Worldwide DMCC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Tris Pharma, Inc. v. Granules Pharmaceuticals, Inc.
as 1:2025cv00498
Plaintiff:
Tris Pharma, Inc.
Defendant:
Granules Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Onyx Therapeutics, Inc. v. Somerset Therapeutics, LLC
as 1:2025cv00500
Plaintiff:
Onyx Therapeutics, Inc.
Defendant:
Somerset Therapeutics, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
